Cholanic acids determined in commercial drugs by means of a new ISFET device.
L Campanella, M Battilotti, A Borraccino, C Colapicchioni, M P Sammartino, M Tomassetti
Index: J. Pharm. Biomed. Anal. 11(11-12) , 1207-14, (1993)
Full Text: HTML
Abstract
An ISFET device selective for cholanic acids, based on a PVC-sebacate membrane, containing benzyldimethylcetylammoniumcholate as exchanger, has been prepared, characterized and applied to the determination of cheno or ursodeoxycholic acid content of commercial pharmaceutical drugs and critical micellar concentration (CMC) values for cholate, deoxycholate and chenodeoxycholate. The results are compared with those obtained using previously described polymeric membrane sensors based on the same exchanger.
Related Compounds
Related Articles:
An efficient synthesis of 4 beta- and 6 alpha-hydroxylated bile acids.
1993-02-01
[Steroids 58(2) , 52-8, (1993)]
2012-10-01
[ChemMedChem 7(10) , 1784-92, (2012)]
Synthesis of [3,4-(13)c(2)]-enriched bile salts as NMR probes of protein-ligand interactions.
2002-09-20
[J. Org. Chem. 67(19) , 6764-71, (2002)]
1995-06-01
[Steroids 60(6) , 453-7, (1995)]
1993-11-01
[Steroids 58(11) , 524-6, (1993)]